Lupin CSR arm, Rajasthan Govt join hands to strengthen Healthcare system

Published On 2022-11-21 07:30 GMT   |   Update On 2022-11-21 11:40 GMT
Advertisement

Jaipur: Lupin Human Welfare and Research Foundation (LHWRF), the Corporate Social Responsibility (CSR) arm of Lupin Limited, announced today that it has signed a Memorandum of Understanding (MoU) with the Government of Rajasthan to address the prevalence of Cardiovascular Disease (CVD) and Chronic Obstructive Pulmonary Disease (COPD) in the Alwar district of Rajasthan.

The MoU was signed in the presence of Dr. K L Meena, Director Public Health, Department of Medical, Health and Family Welfare Government of Rajasthan, and Tushara Shankar, Head – Corporate Social Responsibility, Lupin.

Advertisement

As per the MoU, LHWRF will work with the State's Department of Health and Family Welfare for strengthening the healthcare system and addressing the prevalence of CVD and COPD for better outcomes. The collaboration will work towards serving the local communities in Alwar through preventive, curative, and support-based solutions focused on curing the diseases in the short term and reducing their prevalence in the long term. The program is planned to be rolled out in a phase-wise manner.

Non-communicable diseases (NCDs) contribute to nearly 5.87 million (60%) of all deaths in India. CVD and COPD are two leading causes, but the prevalence rate of CVD and deaths due to COPD in Rajasthan both outpace national figures. Rajasthan is also among the most affected states in terms of respiratory disease. These statistics prompted LHWRF to conduct a comprehensive situation analysis of select healthcare facilities approved by the Department of Medical Health Services (DMHS) in the region. The findings of the assessment were then presented to the DMHS for review on September 21, 2022. The department's inputs and suggestions were incorporated in the final project proposal.

The findings of the analysis have helped co-create a program that would systematically address CVD and COPD in the region. Using an evidence-based approach to design support interventions, six key areas have been identified, which include educating communities, capacity building, early screening, diagnosis & treatment, establishment of NCD corners at health centers, and a patient health tracking system.

"As a leading healthcare provider in India, Lupin has spearheaded the cause of enhancing access to high quality and affordable medicines and healthcare, including to marginalized and vulnerable populations. As we work with the state government to strengthen existing healthcare systems and programs, our goal is to improve availability, accessibility, and utilization of healthcare services," said Nilesh Gupta, Managing Director, Lupin.

"We are registering an increase in CVD and COPD cases in Rajasthan. In order to manage these and other NCD diseases, we have signed an MoU with Lupin Foundation. They will work in selected blocks from Alwar district to fill gaps in awareness and health services by developing NCD corners and delivering services through their mobile diagnostic van," said Dr. K L Meena, Director Public Health, Department of Medical, Health and Family Welfare Government of Rajasthan.

"In Alwar, CVD and COPD remain prevalent despite efforts to promote awareness of these NCDs. This collaboration with the State Government will help us improve health outcomes and reduce the burden of these two major diseases. As part of this program, CVD and COPD healthcare will be enhanced in the blocks of Alwar in a phased manner", said Tushara Shankar, Head – Corporate Social Responsibility, Lupin

Read also: Lupin gets USFDA nod for generic equivalent of Oracea Capsules

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News